| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | A4R7G50030 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Integrin alpha-2 antagonist | Other |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Multiple Sclerosis, Relapsing-Remitting | 2 | D020529 | ClinicalTrials |
| Colitis, Ulcerative | 2 | D003093 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1238217-55-4 |
| ChEMBL | CHEMBL1743086 |
| FDA SRS | A4R7G50030 |
CONTENTS